Department of Medical Sociology and Health Economics, University Medical Center Hamburg-Eppendorf, Martinistr, 52, 20246 Hamburg, Germany.
Health Qual Life Outcomes. 2010 May 5;8:47. doi: 10.1186/1477-7525-8-47.
The EQ-5D is a generic questionnaire which generates a health profile as well as index scores for health-related quality of life that may be used in cost-utility analysis.
To examine validity and responsiveness of the EQ-5D in patients with anxiety disorders.
389 patients with anxiety disorders completed the EQ-5D at baseline and 6-month follow-up. Subjective measures of quality of life (WHOQOL-BREF) and psychopathology (BAI, BDI-II, BSQ, ACQ, MI) were used for comparison. Validity was analyzed by assessing associations between EQ-5D scores and related other scores. Responsiveness was analyzed by calculating effect sizes of differences in scores between baseline and follow-up for 3 groups indicating more, constant or less anxiety. Meaningful difference scores for shifting to less or more anxiety were derived by means of regression analysis.
88.4% of respondents reported problems in at least one of the EQ-5D dimension at baseline; the mean EQ VAS score was 63.8. The EQ-5D dimension most consistently associated with the measures used for comparison was 'anxiety/depression'. EQ VAS and EQ-5D index scores were highly correlated (|r|>0.5) with scores of the WHOQOL-BREF dimensions 'physical', 'mental' and 'overall' as well as BAI and BDI-II. The EQ-5D index tended to be the most responsive score. Standardized meaningful difference scores were not significantly different between EQ VAS, EQ-5D index and measures used for comparison.
The EQ-5D seems to be reasonably valid and moderately responsive in patients with anxiety disorders. The EQ-5D index may be suitable for calculating QALYs in economic evaluation of health care interventions for patients with anxiety disorders.
Current Controlled Trials ISRCTN15716049.
EQ-5D 是一种通用问卷,可生成健康状况概况和健康相关生活质量指数评分,可用于成本效用分析。
检验焦虑障碍患者 EQ-5D 的有效性和反应度。
389 例焦虑障碍患者在基线和 6 个月随访时完成 EQ-5D。使用主观生活质量量表(WHOQOL-BREF)和精神病理学量表(BAI、BDI-II、BSQ、ACQ、MI)进行比较。通过评估 EQ-5D 评分与相关评分之间的关联来分析有效性。通过计算 3 组(焦虑程度增加、不变、减少)评分在基线和随访之间的差异的效应量来分析反应度,3 组分别代表焦虑程度增加、不变和减少。通过回归分析得出向焦虑程度减少或增加转移的有意义的差异评分。
88.4%的受访者在基线时报告至少有一个 EQ-5D 维度存在问题;EQ VAS 平均得分为 63.8。与用于比较的量表最一致相关的 EQ-5D 维度是“焦虑/抑郁”。EQ VAS 和 EQ-5D 指数评分与 WHOQOL-BREF 维度“身体”、“心理”和“总体”以及 BAI 和 BDI-II 的评分高度相关(|r|>0.5)。EQ-5D 指数评分具有中等反应度。EQ VAS、EQ-5D 指数评分和用于比较的量表的标准化有意义差异评分无显著差异。
EQ-5D 在焦虑障碍患者中具有合理的有效性和中等的反应度。EQ-5D 指数可用于计算焦虑障碍患者医疗保健干预的成本效用分析中的 QALY。
当前对照试验 ISRCTN80331024。